Alnylam Pharmaceuticals
David Jones has a solid background in finance, having held various leadership positions in notable pharmaceutical companies such as Alnylam Pharmaceuticals, Incyte, ARIAD Pharmaceuticals, and Edwards Lifesciences. David retired from their most recent role at DRJ. David's education includes a BSc in Accounting and Financial Analysis from the University of Warwick.
This person is not in any offices
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.